Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed May 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$709K
Net Open-Market Flow
-$709K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2026Sell(S)11K$24.71$265K1.1M
May 22, 2026Sell(S)18K$24.44$444K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000164) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.